• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测

Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.

作者信息

Huang Lili, Meng Jixin, Lin Shaochun, Peng Zhenpeng, Zhang Ruonan, Shen Xiaodi, Zheng Weikai, Zheng Qingzhu, Wu Luyao, Wang Xinyue, Wang Yangdi, Mao Ren, Sun Canhui, Li Xuehua, Feng Shi-Ting

机构信息

Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.

Department of Radiology, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, People's Republic of China.

出版信息

J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.

DOI:10.2147/JIR.S524671
PMID:40535353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12174998/
Abstract

PURPOSE

Cumulative bowel damage (BD) critically influences the progression and prognosis of Crohn's disease (CD). Although the Lémann Index (LI) remains the standard for BD assessment, its clinical utility is limited by heavy reliance on extensive clinical data. Multiparametric magnetic resonance enterography (MRE) provides noninvasive macroscopic evaluation of BD severity, however, it fails to characterize microscopic alterations. We therefore integrated MRE with gut microbiome and metabolomic data to uncover mechanistic insights and develop a comprehensive model for better prediction of BD.

METHODS AND RESULTS

In this prospective two-center study, 309 CD patients were stratified into BD and non-BD groups using LI. Patients underwent MRE, fecal 16S rRNA gene sequencing, and fecal/serum metabolomic analysis. Thirty healthy controls were included for comparison. The relationships between microbial/metabolic factors and MRE features were explored using correlation and mediation analyses. Seven machine learning algorithms, each paired with seven distinct combinations of multi-omics features, were evaluated using nested 5-fold cross-validation to construct an optimal prediction model. BD patients exhibited reduced gut microbial diversity (<0.05), with and as key discriminators. Metabolomics revealed elevated fecal aromatic amino acids and depleted serum glycerophospholipids/sphingolipids (<0.05) linked to MRE-quantified features through mediation by microbial pathways (eg, 22.8% mediation effect of on penetration, =0.022). The optimal Xtreme Gradient Boosting Classifier (XGBC) model integrating three microbial genera, six fecal metabolites, three serum metabolites, and three MRE features achieved superior performance (AUC 0.857 and 0.829 in the derivation and external validation cohorts, respectively). SHapley Additive exPlanations (SHAP) analysis prioritized perianal diseases, , and fecal alanine as key contributors.

CONCLUSION

Our study underscores the interplay between gut microbial dysbiosis, metabolic alterations, and MRE-quantified structural changes in BD patients. The integrated multi-omics model provides a promising tool for BD prediction, enabling precise CD severity stratification and personalized clinical decision-making.

摘要

目的

累积性肠道损伤(BD)对克罗恩病(CD)的进展和预后具有关键影响。尽管莱曼指数(LI)仍是评估BD的标准,但它严重依赖大量临床数据,其临床实用性有限。多参数磁共振小肠造影(MRE)可对BD严重程度进行无创宏观评估,然而,它无法描述微观改变。因此,我们将MRE与肠道微生物组和代谢组数据相结合,以揭示其机制,并开发一个综合模型,以便更好地预测BD。

方法与结果

在这项前瞻性双中心研究中,309例CD患者根据LI被分为BD组和非BD组。患者接受了MRE、粪便16S rRNA基因测序以及粪便/血清代谢组分析。纳入30名健康对照进行比较。使用相关性和中介分析探索微生物/代谢因素与MRE特征之间的关系。使用嵌套5折交叉验证评估七种机器学习算法,每种算法与多组学特征的七种不同组合配对,以构建最佳预测模型。BD患者的肠道微生物多样性降低(<0.05), 和 为关键鉴别指标。代谢组学显示粪便芳香族氨基酸升高,血清甘油磷脂/鞘脂减少(<0.05),这些通过微生物途径介导与MRE量化特征相关(例如, 对穿透的中介效应为22.8%,P = 0.022)。整合三个微生物属、六种粪便代谢物、三种血清代谢物和三个MRE特征的最佳极端梯度提升分类器(XGBC)模型表现优异(在推导队列和外部验证队列中的AUC分别为0.857和0.829)。SHapley加性解释(SHAP)分析将肛周疾病、 和粪便丙氨酸列为关键贡献因素。

结论

我们的研究强调了BD患者肠道微生物失调、代谢改变与MRE量化结构变化之间的相互作用。综合多组学模型为BD预测提供了一个有前景的工具,能够实现精确的CD严重程度分层和个性化临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/f2ee70910f62/JIR-18-7631-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/a62b50fcc191/JIR-18-7631-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/128b286b9f00/JIR-18-7631-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/a1ef16a8b4c9/JIR-18-7631-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/2d93b13d3c38/JIR-18-7631-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/70cb0ecb807b/JIR-18-7631-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/753fc8226d38/JIR-18-7631-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/43b61423f3bd/JIR-18-7631-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/f2ee70910f62/JIR-18-7631-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/a62b50fcc191/JIR-18-7631-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/128b286b9f00/JIR-18-7631-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/a1ef16a8b4c9/JIR-18-7631-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/2d93b13d3c38/JIR-18-7631-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/70cb0ecb807b/JIR-18-7631-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/753fc8226d38/JIR-18-7631-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/43b61423f3bd/JIR-18-7631-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c670/12174998/f2ee70910f62/JIR-18-7631-g0008.jpg

相似文献

1
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
2
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.在自闭症群体的参与下为成年自闭症患者调整安全计划。
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
3
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
4
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.
5
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.
6
Microbiome multi-omics analysis reveals novel biomarkers and mechanisms linked with CD etiopathology.微生物组多组学分析揭示了与克罗恩病病因病理学相关的新型生物标志物和机制。
Biomark Res. 2025 Jun 16;13(1):85. doi: 10.1186/s40364-025-00802-1.
7
Stigma Management Strategies of Autistic Social Media Users.自闭症社交媒体用户的污名管理策略
Autism Adulthood. 2025 May 28;7(3):273-282. doi: 10.1089/aut.2023.0095. eCollection 2025 Jun.
8
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
9
Platelet Indices and RDW to Assess Inflammatory Milieu in Subclinical Hashimoto's Thyroiditis.血小板指标和红细胞分布宽度用于评估亚临床桥本甲状腺炎中的炎症环境。
Clin Med Insights Endocrinol Diabetes. 2025 Jun 13;18:11795514251349337. doi: 10.1177/11795514251349337. eCollection 2025.
10
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.

本文引用的文献

1
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease.多组学揭示微生物代谢产物是克罗恩病肠道纤维化的关键因素。
EMBO Mol Med. 2024 Oct;16(10):2427-2449. doi: 10.1038/s44321-024-00129-8. Epub 2024 Sep 13.
2
Crohn's disease.克罗恩病。
Lancet. 2024 Mar 23;403(10432):1177-1191. doi: 10.1016/S0140-6736(23)02586-2. Epub 2024 Mar 1.
3
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts.通过跨队列的多组学整合分析探讨炎症性肠病的微生物组和代谢组特征。
Nat Commun. 2023 Nov 6;14(1):7135. doi: 10.1038/s41467-023-42788-0.
4
, an emerging pathogen that induces lipid raft-mediated cytotoxicity.新型病原体,可诱导脂筏介导的细胞毒性。
Virulence. 2023 Dec;14(1):2265048. doi: 10.1080/21505594.2023.2265048. Epub 2023 Oct 5.
5
Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.肠道微生物代谢物丁酸盐及其在炎症性肠病中的治疗作用:文献综述。
Nutrients. 2023 May 11;15(10):2275. doi: 10.3390/nu15102275.
6
Serum Lipidomic Screen Identifies Key Metabolites, Pathways, and Disease Classifiers in Crohn's Disease.血清脂质组学筛查鉴定克罗恩病的关键代谢物、途径和疾病分类器。
Inflamm Bowel Dis. 2023 Jul 5;29(7):1024-1037. doi: 10.1093/ibd/izac281.
7
Magnetic resonance imaging for evaluation of bowel inflammation and disease activity in Crohn's disease: A systematic review and meta-analysis.磁共振成像评估克罗恩病肠道炎症和疾病活动:系统评价和荟萃分析。
Gastroenterol Hepatol. 2023 May;46(5):336-349. doi: 10.1016/j.gastrohep.2022.10.004. Epub 2022 Oct 13.
8
Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn's Disease.磁共振肠道成像指数对克罗恩病肠腔疾病活动度评估的反应性。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2598-2606. doi: 10.1016/j.cgh.2022.01.055. Epub 2022 Feb 9.
9
Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease.住院的炎症性肠病患者中的无害梭菌感染。
J Infect. 2022 Mar;84(3):337-342. doi: 10.1016/j.jinf.2021.12.031. Epub 2021 Dec 25.
10
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease.多组学揭示了影响炎症性肠病患者对生物治疗反应的微生物决定因素。
Cell Host Microbe. 2021 Aug 11;29(8):1294-1304.e4. doi: 10.1016/j.chom.2021.06.019. Epub 2021 Jul 22.